loss

SolarEdge surges despite posting steep fourth-quarter loss

Read more

Boeing expects $4 billion loss for fourth quarter after chaotic 2024

Read more

Eli Lilly LLY cuts 2024 revenue outlook on weight loss drugs

Read more

High-cost weight loss drugs boost nutrition counseling with employers

Read more

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

Read more

Eli Lilly weight loss drug Zepbound no longer in shortage

Read more

WTI, Brent head to weekly loss

Read more

Flagstar, formerly NYCB, reports a wider-than-expected loss as charge-offs

Read more

Satellite made by Boeing a ‘total loss’ after space ‘anomaly’

Read more

How ‘loss of use coverage’ can help with costs after a natural disaster

Read more